EP01.05: Evaluating therapeutic marker expression and EMT heterogeneity in circulating tumor cells from SCLC liquid biopsies using mass cytometry
Back to course
Pdf Summary
Asset Subtitle
Mukulika Bose
Keywords
mass cytometry
CyTOF
circulating tumor cells
liquid biopsies
Small Cell Lung Cancer
SCLC
biomarker analyses
epithelial-mesenchymal transition
tarlatamab treatment
personalized medicine
Powered By